Integration of Endocannabinoid Signaling into the Neural Network Regulating Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis
- 24 July 2009
- book chapter
- Published by Springer Nature
- Vol. 1, 289-306
Abstract
The evidence that has been gathered to date strongly argues for an inhibitory role of endocannabinoid (ECB) signaling in regulating HPA axis activity. Under basal conditions, ECB signaling appears to be a driving force in the maintenance of low HPA axis activity, as disruption of CB1 receptor activity results in basal hyperactivity of the HPA axis. Under conditions of acute stress, ECB signaling likewise appears to constrain activation of the HPA axis, possibly via both distal regulation of incoming amygdalar inputs and local regulation of excitatory input to CRF neurosecretory cells in the PVN. ECB neurotransmission is, in turn, modulated by stress, possibly acting as either a “gatekeeper” of the HPA axis, or a recovery system aimed at limiting HPA axis activity. Consistently, pharmacological enhancement of ECB signaling attenuates stress-induced HPA axis activity while impairment of CB1 receptor signaling results in an exaggerated cellular and neuroendocrine response to stress. Additionally, under conditions of repeated stress, a progressive increase in limbic 2AG/CB1 receptor signaling contributes to the development and expression of neuroendocrine habituation. Ultimately, these data demonstrate that the ECB system is likely to be an integral player in the neuronal response and plasticity to stress. The relevance of this relationship has not been fully explored with respect to both normal homeostasis and pathological states characterized by alterations in HPA axis function, but will be a focus of future research.Keywords
This publication has 89 references indexed in Scilit:
- Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: A non-genomic anti-inflammatory switchEuropean Journal of Pharmacology, 2008
- Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in miceNeuropharmacology, 2008
- Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in ratsNeuropharmacology, 2008
- Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in micePsychoneuroendocrinology, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and diseaseNeuroscience & Biobehavioral Reviews, 2005
- The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout miceLife Sciences, 2004
- Endocannabinoid hydrolasesProstaglandins & Other Lipid Mediators, 2002
- Arachidonyl Ethanolamide (Anandamide) Activates the Parvocellular Part of Hypothalamic Paraventricular NucleusBiochemical and Biophysical Research Communications, 1997
- Corticosteroids and the Control of Function in the Hypothalamo‐Pituitary‐Adrenal (HPA) AxisaAnnals of the New York Academy of Sciences, 1994